Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy

被引：14
作者：
Sekhar R.V. [1 ]
Jahoor F. [1 ]
Pownall H.J. [1 ]
Ballantyne C.M. [1 ]
Balasubramanyam A. [1 ]
机构：
[1] Division of Endocrinology, Baylor College of Medicine, Houston, TX 77030, One Baylor Plaza
来源：
Current Atherosclerosis Reports | 2004年 / 6卷 / 3期
基金：
美国国家卫生研究院;
关键词：
Insulin Resistance; Cholesteryl Ester Transfer Protein; Lipodystrophy; Postprandial Lipemia; Intramyocellular Lipid;
D O I：
10.1007/s11883-004-0029-2
中图分类号：
学科分类号：
摘要：
The emergence of a new metabolic syndrome in patients with HIV infection, termed "HIV-associated dyslipidemic lipodystrophy" (HADL), is characterized by central fat redistribution, severe dyslipidemia, and insulin resistance and predisposes to an increased risk of cardiovascular disease. The factors promoting the development of cardiovascular disease in this condition are not well understood and may involve contributions from antiretroviral drugs and components of the HIV virus, as well as inflammatory cytokines, leading to accelerated lipolysis, dyslipidemia, lipotoxic insulin resistance, and vascular inflammation. In this article, we review HADL in terms of metabolic, molecular, and cytokine derangements leading to cardiovascular disease. Copyright © 2004 by Current Science Inc.
引用
收藏
页码：173 / 179
页数：6
相关论文
共 50 条
  • [41] Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy
    Ruiz, L
    Negredo, E
    Domingo, P
    Paredes, R
    Francia, E
    Balagué, M
    Gel, S
    Bonjoch, A
    Fumaz, CR
    Johnston, S
    Romeu, J
    Lange, J
    Clotet, B
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (03) : 229 - 236
  • [42] Conjugated Linoleic Acid Isomers Exert Differential Effects on an Adipocyte Model of HIV-associated Lipodystrophy
    Loonam, Cathrona R.
    O'Dell, Sandra D.
    Sharp, Paul A.
    Mullen, Anne
    CURRENT HIV RESEARCH, 2017, 15 (01) : 46 - 55
  • [43] Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials
    Sivakumar, T.
    Mechanic, O. J.
    Fehmie, D. A.
    Paul, B. T.
    HIV MEDICINE, 2011, 12 (08) : 453 - 462
  • [44] Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV-associated lipodystrophy
    Khan, Abdul Arif
    Singh, HariOm
    JOURNAL OF GENE MEDICINE, 2023, 25 (06)
  • [45] Worsening hypertriglyceridemia with oral contraceptive pills in an adolescent with HIV-associated lipodystrophy: a case report and review of the literature
    Patni, Nivedita
    Diaz, Elizabeth G. Lipman
    Cabral, Maria Demma
    Siqueira, Lorena M.
    Diaz, Alejandro
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (11-12) : 1247 - 1251
  • [46] Potential Role of IL-18 in the Immunopathogenesis of AIDS, HIV-Associated Lipodystrophy and Related Clinical Conditions
    Iannello, Alexandre
    Samarani, Suzanne
    Debbeche, Olfa
    Boulassel, Mohamed-Rachid
    Tremblay, Cecile
    Toma, Emil
    Routy, Jean-Pierre
    Ahmad, Ali
    CURRENT HIV RESEARCH, 2010, 8 (02) : 147 - 164
  • [47] From lipodystrophy to cardiovascular disease: new insight into the management of HIV infection
    Guaraldi, Giovanni
    Zona, Stefano
    CLINICAL LIPIDOLOGY, 2010, 5 (04) : 583 - 593
  • [48] Treatment of altered body composition in HIV-associated lipodystrophy: Comparison of rosiglitazone, pravastatin, and recombinant human growth hormone
    Macallan, Derek C.
    Baldwin, Christine
    Mandalia, Sundihya
    Pandol-Kaljevic, Vjera
    Higgins, Nadine
    Grundy, Alan
    Moyle, Graeme J.
    HIV CLINICAL TRIALS, 2008, 9 (04): : 254 - 268
  • [49] Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome
    Sekhar, Rajagopal V.
    Jahoor, Farook
    Iyer, Dinakar
    Guthikonda, Anuradha
    Paranilam, Jaya
    Elhaj, Fareed
    Coraza, Ivonne
    Balasubramanyam, Ashok
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2012, 61 (10): : 1395 - 1403
  • [50] Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy
    Akinci, Gulcin
    Akinci, Baris
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2015, 9 (02) : 74 - 78
12345